Press archive
The 20 recent news
07/02/08, Bayer HealthCare Bayer HealthCare Completes Acquisition of Western OTC Cough and Cold Business of Topsun Science and Technology Significantly Strengthens Consumer Care Division’s Business in High Growth Chinese OTC Market External Link: more
07/02/08, Cardiology/Hematology Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen Phase 1 clinical testing expected to commence in third quarter of 2008 / Transaction includes license to Maxygen’s novel biotechnology research platform External Link: more
06/30/08, Research & Development Rivaroxaban is First Novel Oral Anticoagulant to Significantly Reduce the Composite Outcome of Symptomatic VTE and Death Rivaroxaban shows superior efficacy to enoxaparin for this clinical outcome with a comparable safety profile / Pre-specified analysis of pooled data from RECORD 1-3 studies involving nearly 10,000 pa... External Link: more
06/26/08, Thrombosis New England Journal of Medicine Publishes Results from Two of the Landmark Phase III RECORD Studies with Rivaroxaban Head-to-Head trials involving over 7000 patients after Major Orthopedic Surgery / Rivaroxaban superior to Enoxaparin in Preventing Venous Blood Clots / Bleeding rates were low and comparable between ... External Link: more
06/25/08, Research & Development The Lancet Publishes Results from the Landmark Phase III Rivaroxaban Study RECORD2 Trial involving over 2.500 patients after hip replacement surgery / Five weeks of Rivaroxaban compared to two weeks enoxaparin / Extended Rivaroxaban treatment regimen significantly more effective wi... External Link: more
06/24/08, Gynecology/Andrology Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States Appeal of court decision invalidating Yasmin patent will continue / Further growth of Bayer’s Women’s Healthcare Business Unit expected External Link: more
06/19/08, Bayer Schering Pharma Leading scientists review the latest research Numerous studies confirm the safety and efficacy of Aspirin External Link: more
06/18/08, Worldnews Bright prospects for animal health products from Kiel Ceremony attended by Minister-President Carstensen and Mayoress Volquartz External Link: more
06/05/08, Worldnews European Journalists’ Prize goes to Poland and Germany Pawel Walewski honored for his report on the problems that cancer patients have with coping / Anahita Parastar receives prize for her report “Coma – is there a way back to life?” External Link: more
06/05/08, Stories Sahara by bicycle 2,000 kilometers through the desert External Link: more
06/03/08, Bayer Schering Pharma Bayer HealthCare Commits US-Dollar 2.5 Million in Funding to Advance Global Hemophilia Research and Patient Care Industry-Leading program supports cutting-edge research and clinical projects External Link: more
06/03/08, Bayer HealthCare Bayer HealthCare successfully completes acquisition of Sagmel, Inc.’s OTC Business Bayer Consumer Care’s Presence in Eastern Europe Significantly Strengthened External Link: more
06/02/08, Oncology New Nexavar® Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology (ASCO) Annual Meeting Berlin/Chicago, June 2, 2008 – Bayer HealthCare and Onyx Pharmaceuticals, Inc. today announced the presentation of new clinical data from Phase II trials in the development program for NexavarÂ... External Link: more
05/30/08, Research & Development Rivaroxaban One Tablet/Once-Daily Superior to Twice-Daily Injectable Enoxaparin in Preventing Venous Blood Clots after Total Knee Replacement Surgery in Pivotal Phase III Trial Rivaroxaban is First Oral Anticoagulant to Achieve Superior Efficacy over the Twice-Daily Injection of Enoxaparin while Maintaining Low Major Bleeding Rates / RECORD4 Confirms Results of RECORD1, 2 a... External Link: more
05/28/08, Worldnews Bundeskartellamt ends lawsuit against Bayer Vital Leverkusen, May 28, 2008 – The German Bundeskartellamt (BKartA) has ended its lawsuit against Bayer Vital GmbH and imposed a fine. The BKartA believes that it has evidence to show that employee... External Link: more
05/19/08, Primary Care Amikacin Inhale shows promising results in Phase II Study Bayer together with Nektar Therapeutics present preliminary Phase II data for the adjunctive treatment of pneumonia in intubated and mechanically-ventilated patients External Link: more
05/19/08, Oncology Reformulated Liquid Leukine® Now Available in the U.S. EDTA removed from liquid formulation / Restoration of U.S. supplies of Leukine External Link: more
05/16/08, Specialized Therapeutics Bayer Schering Pharma Starts Global Awareness Campaign – Mastering MS – to Provide Hope for People in Meeting the Daily Challenges of Multiple Sclerosis International survey reveals most people with multiple sclerosis worry about the future External Link: more
05/16/08, Bayer Schering Pharma High pace of integration maintained Positive development of business in the first quarter of 2008 External Link: more
05/16/08, Oncology Nexavar Significantly Extends Overall Survival in Liver Cancer by 47 percent Trial Results Confirm Efficacy for Population Most Affected by the Disease External Link: more
top of page